Eyes on the Prize: Progress in Cystic Fibrosis Research Amidst a Pandemic
Just over one year ago, COVID-19 exploded on news headlines — putting the world in a tizzy about what this new virus was, who was at risk and how to prevent…
Update your location to show providers, locations, and services closest to you.
Just over one year ago, COVID-19 exploded on news headlines — putting the world in a tizzy about what this new virus was, who was at risk and how to prevent…
Clinicians frequently overlook nonalcoholic fatty liver disease in their patients who have Type 2 diabetes. Yet it is estimated that approximately 70% of obese…
Nonalcoholic fatty liver disease is a growing worldwide health problem and has been linked to common disorders such as Type 2 diabetes and cardiovascular…
Nonalcoholic steatohepatitis, or NASH, is a serious progression of nonalcoholic fatty liver disease. Percutaneous liver biopsy is currently the gold standard…
Researchers at University of Florida Health have played a pivotal role in developing new treatments and improving health outcomes for patients with hepatitis…
Dear colleagues, At University of Florida, the Division of Endocrinology, Diabetes and Metabolism is conducting leading-edge research to learn more about the…
Despite decades of research and thousands of articles on the subject, clinicians are no closer to finding the ideal diet for patients with diabetes than when…
For most adults, moderate drinking does not cause health problems. Moderate drinking is defined as no more than one drink a day for women and two drinks a day…